cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Profound Medical Corp
2 own
3 watching
Current Price
$13.39
$1.25
(10.3%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
279.2M
52-Week High
52-Week High
13.95
52-Week Low
52-Week Low
3.1
Average Volume
Average Volume
0.08M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization279.2M
icon52-Week High13.95
icon52-Week Low3.1
iconAverage Volume0.08M
iconDividend Yield--
iconP/E Ratio--
What does the Profound Medical Corp do?
Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops magnetic resonance guided ablation procedures for treatment of prostate disease, uterine fibroids, and palliative pain treatment in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system used for magnetic resonance imaging scanner in hospitals and treatment facilities. The company also offers Sonalleve, a therapeutic platform for the treatment of uterine fibroids and palliative pain relief associated with metastases in bone, as well as non-invasive treatment of uterine fibroids. Profound Medical Corp. is headquartered in Mississauga, Canada.
Read More
News & Events about Profound Medical Corp.
Globe Newswire
8 months ago
TORONTO, Sept. 26, 2022 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (Profound or the Company), a commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue, announced that updated results from the ...
Globe Newswire
9 months ago
TORONTO, Sept. 02, 2022 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (Profound or the Company), a commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue, today provided a U.S. reimbursement ...
Ticker Report
9 months ago
Profound Medical Corp. (NASDAQ:PROF Get Rating) Research analysts at Leede Jones Gab reduced their FY2025 earnings per share (EPS) estimates for shares of Profound Medical in a report released on Monday, August 8th. Leede Jones Gab analyst D. Loe now expects that the company will ...
Ticker Report
9 months ago
Profound Medical (NASDAQ:PROF Get Rating) had its price target decreased by Raymond James from $17.50 to $15.00 in a report published on Monday, BayStreet.CA reports. Raymond James currently has an outperform rating on the stock. Separately, Alliance Global Partners cut their price target on...
Zolmax
9 months ago
Profound Medical (NASDAQ:PROF Get Rating) had its price target lowered by Raymond James from $17.50 to $15.00 in a research report released on Monday morning, BayStreet.CA reports. The brokerage currently has an outperform rating on the stock. Separately, Alliance Global Partners dropped their price...
Frequently Asked Questions
Frequently Asked Questions
What is Profound Medical Corp share price today?
plus_minus_icon
Can Indians buy Profound Medical Corp shares?
plus_minus_icon
How can I buy Profound Medical Corp shares from India?
plus_minus_icon
Can Fractional shares of Profound Medical Corp be purchased?
plus_minus_icon
What are the documents required to start investing in Profound Medical Corp stocks?
plus_minus_icon
What is today’s traded volume of Profound Medical Corp?
plus_minus_icon
What is today’s market capitalisation of Profound Medical Corp?
plus_minus_icon
What is the 52-Week High and Low Range of Profound Medical Corp?
plus_minus_icon
What percentage is Profound Medical Corp down from its 52-Week High?
plus_minus_icon
What percentage is Profound Medical Corp up from its 52-Week Low?
plus_minus_icon
Current Price
$13.39
$1.25
(10.3%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Related Stocks
Sign up and dive into a whole new world of investing.
Join over 370,000 who have signed up and are using Stockal successfully already.
Related Stocks
Sign up and dive into a whole new world of investing.
Join over 370,000 who have signed up and are using Stockal successfully already.

              Borderless Investing Inc., (“Borderless Investing”), the owner of the Stockal Platform, is not a broker-dealer nor an investment advisor and through its affiliate stockbroker Stockal Securities Pvt. Ltd., (SEBI INZ000301236), acting as the introducing entity has entered into a clearing agreement with DriveWealth LLC., to offer U.S. equities on the Stockal Platform. The Stockal Platform enables investments in a diverse set of global assets from a single account from anywhere in the world. As such, Borderless Investing makes no warranties or representations, express or implied, on products and services offered through its website/platform. It accepts no liability for any damages or losses, however, caused in connection with the use of related services.

              All investments involve risk and returns will fluctuate, are subject to market volatility and may cause losses. The material on this website/platform is provided solely for informational and educational purposes and shall not in any manner be considered a recommendation or endorsement of any strategy or investment, nor an offer to sell or a solicitation of an offer to buy securities, products or services nor advice. Borderless Investing makes no guarantee as to the currency, accuracy, or quality of information published and/or archived on this website/platform, nor will Borderless Investing accept any responsibility for other organizations, businesses, and private persons that provide information on this website/platform. All information on this website/platform regarding products and services provided by Borderless Investing is subject to change without notice. Reasonable efforts are taken to ensure the accuracy and integrity of all information provided here, but Borderless Investing is not responsible for misprints, out of date information, or errors. Any investment decision and/or strategy that investors make or employ, whether or not such decision or strategy derives from or relies upon material accessed or provided through this website/platform, is undertaken at the investor’s sole discretion and risk. Before making any investment decisions, investors should consult additional sources of information and/or their legal or tax advisor. PLEASE READ THIS FULL DISCLOSURE CAREFULLY BEFORE USING THIS SERVICE. BY USING THE SERVICE OR CLICKING AGREE YOU ARE AGREEING TO BE BOUND BY THESE DISCLOSURES AND ALL TERMS AND CONDITIONS ON THIS WEBSITE/PLATFORM.

              *DriveWealth LLC., a member of the Securities Investor Protection Corporation (SIPC), will serve as the custodian for your securities account. In the event that DriveWealth LLC., fails and is placed in liquidation under the Securities Investor Protection Act, securities in your brokerage account may be protected up to $500,000. For details, please see www.sipc.org.

              All brands and logos used on this website are the property of their respective owners.

              Get Started with as little as $1.00